chrisvoncsefalvay/vaers-outcomes huggingface dataset:
experienced lasting effect permanent cognitive/neurological decline after 2nd dose.; experienced lasting effect permanent cognitive/neurological decline after 2nd dose.; short term memory loss.; unable to articulate the language arts side of the brain, even though high professional performer; This is a spontaneous report from a contactable other hcp (patient). A 41-years-old non-pregnant female patient received bnt162b2 (Pfizer, covid 19, formulation: solution for injection, Batch/Lot Number: el9262), via an unspecified route of administration, administered in Arm Left on 19Feb2021 13:45 (at the age of 41-years-old) as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications ware not reported. The patient had no allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medication in two weeks. The patient previously took bnt162b2 (Pfizer, covid 19, formulation: solution for injection, Batch/Lot Number: el3249), via an unspecified route of administration, administered in Arm Left on 21Jan2021 01:15 (at the age of 41-years-old) as dose 1, single for covid-19 immunisation. On 22Feb2021, the patient experienced lasting effect permanent cognitive/neurological decline after 2nd dose, short term memory loss, unable to articulate the language arts side of the brain, even though high professional performer. Therapeutic measures were taken as a result of experienced lasting effect permanent cognitive/neurological decline after 2nd dose. (neuropathy peripheral), experienced lasting effect permanent cognitive/neurological decline after 2nd dose. (cognitive disorder), short term memory loss. (amnesia), unable to articulate the language arts side of the brain, even though high professional performer (language disorder). The clinical outcome of the events was not recovered.  Case comment: Based on the information in the case report and a plausible temporal relationship, a possible causal relationship between Neuropathy peripheral, cognitive deterioration, amnesia, language disorder and suspect product bnt162b2 cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product was evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Left eye ball/socket soreness when moving side to side, up and down; Sinus pressure left eye; This is a spontaneous report from a contactable other hcp.  A 42-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), (lot number: El3248), intramuscular, in the left arm, on 08Jan2021 16:45 at single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported. Patient received the first dose of BNT162B2 on an unspecified date for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19.  The patient experienced "left eye ball/socket soreness when moving side to side, up and down" and sinus pressure left eye on 10Jan2021 10:00. the outcome of events was recovering.  Therapeutic measure taken as a result events included Sufdafed.  No follow-up attempts are possible. No further information is expected. Information on the lot/batch number has been obtained.
Information has been received from a registered nurse concerning a 25 year old female with no drug reactions or allergies with hypertension and asthma who on 13-APR-2007 was vaccinated intramuscularly into the left deltoid muscle with the first dose of Gardasil, (Lot # 656050/0245U). Concomitant therapy included ethinyl estradiol/norgestimate (ORTHO TRI-CYCLEN LO), fexofenadine hydrochloride (+) pseudoephedrine hydrochloride (ALLEGRA-D), hydrochlorothiazide (manufacturer unknown), albuterol, bupropion HCl (WELLBUTRIN), atomoxetine hydrochloride (STRATTERA) and venlafaxine HCl (EFFEXOR). On 13-APR-2007 the patient developed hives after receiving her first dose of Gardasil. The hives were mostly on her vaccinated arm. The patient sought unspecified medical attention. The hives disappeared the next day, 14-APR-2007. No further information was available. Additional information has been requested. 10/08/07 This is in follow-up to report(s) previously submitted on 7/16/2007. In follow-up it was reported that the patient was a female with an allergy to cat hair, asthma and hypertension, who reported an annual gynecology exam with no significant problems. It was reported the patient received the GARDASIL in the left deltoid muscle on 13-APR-2007 at 10:00 a.m. It was reported that on 13-Apr-2007, the patient experienced hives on the left arm in the afternoon of the day of injection and went into the evening. The hives were "stnowen" on 14-APR-2007. It was reported the patient recovered on 14-APR-2007. Additional information has been requested.
cried for 3 days off & on-not high pitched-fever w/APAP 101-102-large red knot on rt leg @ inj site-hard to touch
Patient with 2 Moderna COVID vaccinations who admitted to hospital with rectal bleeding and had an incidental positive COVID test.  No s/s of respiratory distress during admission.  Provider discharge note below:  "Brief Summary of Hospital Stay:  Patient is a 69 YO female presented with rectal bleeding, epistaxis and extensive bruising. Labs notable for pancytopenia with severe thrombocytopenia. During her hospitalization stay, she was started on Cefepime for prophylaxis and also received Filgrastim and Rituxan per guidance of her Oncologist. Home Eliquis was held. After few days of hospitalization, her bleeding has resolved, ecchymosis improved with resolving pancytopenia. On day of discharge, she received her dose df weekly Rituxan. Her vitals remain stable and she remained symptom free.    Issues Requiring Follow Up: Pancytopenia: follow up with Doctor: determine safe time to re start Eliquis for prior DVT Hypertension: started on Norvasc: follow up with PCP"
p/vax had rash to appear on both feet;rash spread up legs to torso & arms;no redness, swelling or warmth @ site of inj;pt did not exp wheezing or hives, no fever;advised to take to MD;dx rxn to hep b vax;
Vulvar ulcers on labor minora. I looked up that this is something that can happen after a serious I?ll was. I haven?t had any illness.  It is definitely ulcers.
Fever of 104 for 24 hours. Cool bath at onset, ped Motrin, Tylenol (pediatric) given. Alternated every four-five hours. Temp went down to 102. Soreness at injection site for 2 days. temp onset at 6 am the next day (about 14 hours later). Temp back to normal 24 hours after onset.
Had Covid vaccine Friday morning, Saturday morning  at breakfast started shaking, couldn't talk.  Called 911 and treated for TIA.  Received blood thinners, had CT scan . MRI, and echo gram on heart.   Released from hospital Monday morning, no after effects.
Shaking chills; Sweats starting 12 hours after dose while sleeping; Migraine headache for a continuous 36 hours; Nausea; This is a spontaneous report from a contactable Nurse (reporting for herself). A 37-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- UNKNOWN) via an unspecified route of administration in right arm on 12Jan2021 09:15 as 2nd single dose and had previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- UNKNOWN) via an unspecified route of administration as 1st single dose for COVID-19 immunization. Patient was 37-years-old and was not pregnant at the time of vaccination. Patient Vaccination facility type was Hospital. Patient did not receive any other vaccine in four weeks. Patient did not receive any prior COVID-19 vaccination. Patient was not tested for COVID-19 post vaccination. On 12Jan2021 patient experienced shaking chills/sweats starting 12 hours after dose while sleeping, no fever. Migraine headache for a continuous 36 hours and nausea. Patient did not receive any treatment for the adverse event. The outcome of the event was recovered.   Information about Lot/ Batch has been requested.  Follow-up (16Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
This spontaneous report was received from a medical assistant, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug reactions, allergies and concomitant medications were not reported. On 01-MAY-2018, the patient was vaccinated with an improperly stored GARDASIL 9 for prophylaxis, lot #N025428 and expiration date 19-JUN-2020 (strength, dose, frequency and route of administration were not reported). No adverse effect was reported. The temperature of excursion was reported as below 30°F (-40°F), during a time frame of 4 hours and 7 minutes. There was no previous temperature of excursion reported. A digital data logger was involved. This is one of several reports received from the same source. Sender's Comments: US-009507513-1806USA003811: US-009507513-1806USA007091: US-009507513-1806USA007092: US-009507513-1806USA007093.
diagnosed with Shingles/quite a few sores of the shingles; This is a spontaneous report from a contactable consumer (patient). A 66-year-old female patient received bnt162b2 (BNT162B2 also reported as PFIZER-BIONTECH COVID-19 VACCINE), dose 1 at vaccination age of 66-year-old via an unspecified route of administration on 13Mar2021 (Batch/Lot number was not reported) as first dose, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported.  The patient reported that she received her first dose of the Pfizer-Biontech Covid19 vaccine on 13Mar2021 and she has since developed and broke out with shingles 4 days ago"(26Mar2021) and she reported "quite a few sores" (quite a few sores of the shingles). She was diagnosed with shingles between Covid19 vaccine doses and may delay her second dose if possible. She is scheduled to get her second dose this Saturday (03Apr2021). She inquired if she should receive her second dose as schedule or defer until her shingles outbreak has resolved. She added that she saw her doctor for treatment of the shingles, and he prescribed her a medication. She mentioned that he didn't have any idea what to do about receiving the second Covid19 vaccine. The outcome of the events was unknown.  No follow-up attempts are completed; information about lot/batch number cannot be obtained.
following morning i contacted my Doctor to do a telehealth because i have an Auto immune disease and i started to run extremely high fevers 102.8 -103.6.  I had also noticed some memory issues after dose # 1 and they seemed to get worse with 2nd dose. couldnt recall my own telephone number. forgot the pin to my debit card would walk into a room and forget why misplace items keys, phone, medication bottles. had to set alarms in phone because i cant remember if i took my medication and had to count pills to see if i did  or not. the fevers lasted 4 days and other then memory issues i feel normal. was also exposed to a patient at work on 09/06 that is now admitted at hospital with covid and she was fully vaccinated. i went and got tested yesterday and will retest again after 5 days from exposure
Father brought in daughter and son for #1 Moderna vaccines. Reported he and mother had been vaccinated with Moderna and wanted to get kids started. RN looked up brother (older) - he was unvaccinated for Covid. Administration of covid vaccines complete. When entering vaccine, this RN saw that she was previously vaccinated. Father was unsure - said maybe they had gotten it started awhile ago but was unsure.  Client waited in clinic for 30 minutes before leaving and no immediate adverse effects were experienced. Department of Health was alerted and notified of situation. They advised VAERS be completed.
localized reaction 65x4cm red raised, warm then progressed to 92mm x 57;seen for cellulitis given ancef then placed on PO keflex;
Case number PHEH2013US024850, is an initial spontaneous report received from a pharmacist on 25 NOV 2013. This report refers to a 76-year-old female patient. Past medical history and concomitant medication were not reported. She was inadvertently vaccinated with MENVEO (batch number: A11077 and expiry date: APR 2014), at a dose of 0.5 ml intramuscularly on 24 NOV 2013. No adverse event was reported following this administration error.
Pt was vaccinated on 7/21/00. Mom reported rash (maculo-papular/whelp-like) on trunk and back on 7/22/00. This cleared and then had some on face. On 7/23/00, seen at office visit; 7/24/00 in the early morning, still had rash on trunk and back consistent with heat rash. Recommended no further Prevnar vaccines.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 59-year-old female patient who received SHINGRIX for prophylaxis. On 18th April 2019, the patient received the 1st dose of SHINGRIX. On 18th April 2019, less than a day after receiving SHINGRIX, the patient experienced pain in arm and injected limb mobility decreased. On an unknown date, the outcome of the pain in arm and injected limb mobility decreased were not recovered/not resolved. It was unknown if the reporter considered the pain in arm and injected limb mobility decreased to be related to SHINGRIX. Additional details were provided as follows: This case was reported by the patient for herself. The age at vaccination was not reported. The patient reported to have sore, painful arm at the injection site after receiving the SHINGRIX vaccine on the date of reporting. The patient also had difficulty raising her arm. The patient did not specify if it was dose 1 or 2, however the representative got the impression it was her first dose due to the nature of the call. The patient did not give consent to be followed up. The patient declined healthcare professional (HCP) consent and date of birth and provided limited capturing information.
Pt recv vax on 3/5/99; on 3/8/99 pt exp rash on legs & hives
The patient complains of having a numbing sensation in the left arm approximately 1 month after receiving the vaccine. He isn't sure if that is caused by vaccination or any other unknown causes.
tingling in hands and feet that lasted for weeks; had brain fog; had a lot of reactions; covid arm; Headache; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PARAESTHESIA (tingling in hands and feet that lasted for weeks), FEELING ABNORMAL (had brain fog), ADVERSE REACTION (had a lot of reactions), VACCINATION SITE REACTION (covid arm) and HEADACHE (Headache) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (tingling in hands and feet that lasted for weeks), FEELING ABNORMAL (had brain fog), ADVERSE REACTION (had a lot of reactions), VACCINATION SITE REACTION (covid arm) and HEADACHE (Headache). At the time of the report, PARAESTHESIA (tingling in hands and feet that lasted for weeks), FEELING ABNORMAL (had brain fog), ADVERSE REACTION (had a lot of reactions), VACCINATION SITE REACTION (covid arm) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Patient has had a painful left jaw for several days, with no other symptoms.  On physical exam today, he has a mild parotitis.  Patient was advised to avoid spicy or sour foods, to eat foods that don't require a lot of chewing, and to take Ibuprofen as needed for pain.
Red, hot to touch, raised swelling larger by day at injection site. Head aches daily since injection. Pain in elbow and pinky finger on third day since vaccine.
pt recv vax 20MAY98 & fever to 103.2 24MAY98;
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding concurrent conditions, medical history, or concomitant medications. In June 2014, a pharmacist at a pharmacy administered ZOSTAVAX to the patient to obtain permanent prevention and protection against shingles and zoster-related injuries/conditions (dose, route, and lot # not provided). On or about 09-SEP-2014, the patient was treated by a physician at a medical center for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with ZOSTAVAX, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries.  As a direct and proximate result of ZOSTAVAX, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was not recovered. Causality assessment was related. Additional information has been requested.
After the expected fever, I started to develop heart palpitations the next day. I had ongoing, random bouts of heavy palpitations over the next week. Out of breath when even walking up stairs. Pounding heart especially when laying down. 1 week after first shot developed chest pain/rib pain. Extremely sore to breath in and also to the touch. Feels like inflammation on ribs/sternum. This lasted 2 days. Started feeling normal again after 9 days but when I try to do activities I am quickly out of breath and my heart pounds more than usual. I had a previous covid infection in March 2020 with similar out of breath feeling with no lung issues. Still have some continuing arm pain & bruising 11 days after first shot but is manageable.
Pt received her Moderna 0.25 ml booster shot today at 0954. Pt began to experience flushing to neck and chest area, coupled with severe itching within ten mins of receiving injection. Pt was brought to triage area. Vital signs were taken and WNL. No c/o of SOB or dizzyness. Notified Dr and recvd verbal order for Zyrtec 10mg dissolvable tab PO x 1. Admin medication at 1014 and Vitals retaken 15mins later. Vitals retaken at 1045,VSS, redness and itching resolved. Pt D/Cd home and advised to monitor to a return of symptoms or SOB and act accordingly.
3/30/07 10:00 AM HPV vaccine was administered on her left upper arm sitting on an exam table. 2-3 minutes after administering vaccine, pt. c/o a headache and dizziness. Pt. was placed on exam table in a laying position.
15 minutes after receiving the COVID injection patient started to feel left side upper body numbness. No medications given.  Patient discharged
had strange vision issues where I am dizzy and then I see spots and distortion of what is in front of me off and on; extreme dizziness and tiredness; extreme dizziness and tiredness; infectious mononucleosis; had a lot of brain fog; extreme lethargy to the point of wanting to sleep it off every single day no matter how long she slept; sore all over her body like her joints are sore all over her body; sore all over her body like her joints are sore all over her body; hot flashes like when she went into menopause in the past; all she wanted to do was sleep all the time; This is a spontaneous report from a contactable consumer (patient). A 59-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 11Apr2021 09:15 (Batch/Lot Number: ew0153) as single dose for covid-19 immunisation.  Medical history included hot flush from an unknown date and unknown if ongoing (went into menopause in the past), menopause from an unknown date and unknown if ongoing menopause.  The patient previously took Tequin and experienced allergy. Patient reported of taking daily vitamins and supplements in 2 weeks timeframe of vaccination. There were no other vaccines in 4 weeks. Patient did not have COVID prior to vaccination. On Day 1, 11Apr2021 at 09:15 am, the patient experienced extreme dizziness and tiredness. Day two and on, patient still getting the side effects. Patient stated "I felt like I have mono". She expressed that  she was "dog tired" every single day. She reported of also had a lot of brain fog. She had extreme lethargy to the point of wanting to sleep it off every single day no matter how long she slept. Patient reported of also experienced "strange vision issues where I am dizzy and then I see spots and distortion of what is in front of me off and on". The patient was sore all over her body like her joints are sore all over her body. She experienced hot flashes like when she went into menopause in the past. All of these symptoms come and go but the lethargy and brain fog continued and has not gone away now 12 days has past since she got her first shot. She stated that all she wanted to do was sleep all the time. The outcome of events was not recovered. No treatment was received. Patient did not test for COVID post vaccination.
Inappropriate age at vaccine administration; This spontaneous report has been received from a lawyer, via immunization record from a case in litigation for HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) (MARRS # 2303USA000135), concerning a 11-year-old male patient (pt). Concomitant vaccines included hepatitis a vaccine (+) inactivated (VAQTA), pneumococcal vaccine conj 13v (crm197) (PREVNAR 13) and meningococcal vaccine a/c/y/w conj (dip tox) (MENACTRA). Information about concurrent condition and medical history was not reported.   On 01-APR-2014, the pt was vaccinated with a dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) administered orally for prophylaxis (strength, dose, lot #, and expiry date were not provided) (product administered to patient of inappropriate age).  This is one of several reports for the same pt.; Sender's Comments:  US-009507513-2303USA000135:
Severe headache  Nausea Dizziness  Began approx 2 hours after vaccination
Pt reported severe pain, swelling, and itching within 2 hours of injection time. Pain continued to increase as well as redness around injection site. Pt then began experiencing widespread hives starting on 5/11/18 and was seen at the Emergency Department that evening.
patient became light-headed  10 minutes after Moderna vaccine. then complained of burning down mouth and jaw, and then right leg.  then became short of breath. O2 applied, oximeter at 100%.  Benadryl 50 mg given IM to left deltoid. called 911.  Dr. notified